Related Experiment Video

Updated: Apr 30, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

9.8K

Catechin ameliorates cardiac dysfunction in rats with chronic heart failure by regulating the balance between Th17

Qi Zhang1, Li-Qun Hu, Chang-Sen Yin

  • 1Geriatric Department of the Affiliated Provincial Hospital of Anhui Medical University, Anhui Institute of Cardiovascular Disease, Hefei, 230001, China, zhangqi19982003@126.com.

Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|April 25, 2014
PubMed

Insights

Catechin effectively treats chronic heart failure (CHF) in rats by improving heart function and regulating immune cells, specifically T helper 17 (Th17) and regulatory T (Treg) cells. This study highlights catechin

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Pharmacology

Background:

  • Cytokine network imbalance is implicated in chronic heart failure (CHF) progression.
  • Catechin demonstrates cardioprotective effects in various heart conditions.
  • The specific impact of catechin on CHF and its immunomodulatory mechanisms remain largely unexplored.

Purpose of the Study:

  • To evaluate the efficacy of catechin in a rat model of CHF.
  • To investigate the relationship between catechin treatment and immunoregulation in CHF.

Main Methods:

  • Chronic heart failure (CHF) induced in rats via abdominal aortic ligation.
  • Myocardial function assessed by left ventricular pressures.
  • Cytokine levels (IL-17, IL-10) and Th17/Treg cell populations measured using ELISA and flow cytometry.

Main Results:

  • Catechin treatment significantly improved cardiac function in CHF rats.
  • Myocardial dysfunction severity correlated with serum IL-17/IL-10 ratios.
  • Catechin inhibited immune activation, balanced IL-17/IL-10 levels, and corrected Th17/Treg cell polarization.

Conclusions:

  • Oral catechin administration effectively mitigated abdominal aorta ligation-induced CHF in rats.
  • Catechin's therapeutic effects are closely linked to its modulation of Th17 and Treg cells.
Abstract

More Related Videos

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model10:18

Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model

Published on: June 29, 2014

16.4K
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

750

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.7K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626